Suchergebnisse - "Itolizumab"

PubPharm (15)

1

Comparative evaluation of tocilizumab and itolizumab for treatment of severe COVID-19 in India : a retrospective cohort study

enthalten in: Acute and critical care | 2024

von Kumar, A. | Kumar, N. | Pattanayak, A. | +4

2

REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19 : a multicenter, single-arm, Phase IV itolizumab Trial: RESURRECT

enthalten in: Expert opinion on biological therapy | 2023

von Kr, R. | Rathod, C. | Darnule, R. | +8

3

Pharmacological treatment of COVID-19 : an opinion paper

enthalten in: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia | 2022

von García-Lledó, A. | Gómez-Pavón, J. | González Del Castillo, J. | +12

4

A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19

enthalten in: Expert opinion on biological therapy | 2021

von Kumar, S. | De Souza, R. | Nadkar, M. | +7

5

Off-label Use of Itolizumab in Patients with COVID-19 ARDS : Our Clinical Experience in a Dedicated COVID Center

enthalten in: Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine | 2021

von Kumari, P. | Kumar, A. | Sinha, C. | +3

6

An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome : report of three cases

enthalten in: Immunotherapy | 2021

von Filgueira, L. | Cervantes, J. | Lovelle, O. | +14

7

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

enthalten in: Immunity & ageing : I & A | 2020

von Saavedra, D. | Añé-Kourí, A. | Sánchez, N. | +14

8

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

enthalten in: Immunity & ageing | 2020

von Saavedra, D. | Añé-Kourí, A. | Sánchez, N. | +14

9

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

enthalten in: Immunity & ageing | 2020

von Saavedra, D. | Añé-Kourí, A. | Sánchez, N. | +14

10

Are We Jumping the Gun with Itolizumab in India? A Situational Analysis from the Pre-COVID Era

enthalten in: SN comprehensive clinical medicine | 2020

von Thangaraju, P. | Venkatesan, N. | Thangaraju, E. | +1